NextCure, Inc.

SEC filing

Biotechnology · Beltsville, MD

Form D on EDGAR

Amount raised$21.5Msold at filing

Total offering$21.5M

Investors in the raise12count reported to the SEC

FiledDec 10, 2025first sale Nov 12, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Timothy G. MayerExecutive Officer

Michael RichmanExecutive Officer, Director

Elaine V. JonesDirector

Udayan G. GuhaExecutive Officer

Anne G. BorgmanDirector

Steven P. CobournExecutive Officer

David P. KabakoffDirector

Sourav G. KunduExecutive Officer

Ellen G. FeigalDirector

Stephen G. WebsterDirector

John G. HoustonDirector

Kevin G. ShawExecutive Officer

Executive officers, directors and promoters as listed on the Form D.